Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 3
1973 9
1974 7
1975 11
1976 12
1977 12
1978 21
1979 11
1980 22
1981 23
1982 21
1983 22
1984 12
1985 14
1986 19
1987 20
1988 24
1989 21
1990 33
1991 20
1992 16
1993 17
1994 14
1995 24
1996 11
1997 10
1998 12
1999 7
2000 7
2001 8
2002 7
2003 3
2004 4
2005 6
2006 6
2007 8
2008 4
2009 2
2010 3
2011 4
2012 5
2013 3
2014 8
2015 8
2016 6
2017 6
2018 1
2019 4
2020 5
2021 1
2022 5
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

554 results

Results by year

Filters applied: . Clear all
Page 1
Colestipol.
[No authors listed] [No authors listed] 2017 Sep 28. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Sep 28. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643751 Free Books & Documents. Review.
Colestipol is a nonabsorbed bile acid sequestrant that is used a therapy of hyperlipidemia and for the pruritus of chronic liver disease and biliary obstruction. Colestipol has not been associated with clinically apparent liver injury....
Colestipol is a nonabsorbed bile acid sequestrant that is used a therapy of hyperlipidemia and for the pruritus of chronic liver dise
Colestipol.
[No authors listed] [No authors listed] 2022 Sep 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2022 Sep 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000452 Free Books & Documents. Review.
Colestipol is a nonabsorbable resin. Because it does not enter the mother's bloodstream, it will not reach the infant via breastmilk. ...
Colestipol is a nonabsorbable resin. Because it does not enter the mother's bloodstream, it will not reach the infant via breastmilk.
Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.
Davies NM, Anderson KE. Davies NM, et al. Clin Pharmacokinet. 1997 Sep;33(3):184-213. doi: 10.2165/00003088-199733030-00003. Clin Pharmacokinet. 1997. PMID: 9314611 Review.
Significant drug interactions have been demonstrated for aspirin (acetylsalicylic acid), lithium, digoxin, methotrexate, cyclosporin, cholestyramine and colestipol....
Significant drug interactions have been demonstrated for aspirin (acetylsalicylic acid), lithium, digoxin, methotrexate, cyclosporin, choles …
Colestipol.
Hameed MH, Patel P, Farzam K. Hameed MH, et al. 2024 Jan 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2024 Jan 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 36508523 Free Books & Documents.
Colestipol is an antihyperlipidemic drug approved by the United States Food and Drug Administration (FDA) as an adjunctive therapy to lower elevated low-density lipoprotein cholesterol in patients with primary hypercholesterolemia unresponsive to dietary modifications alon
Colestipol is an antihyperlipidemic drug approved by the United States Food and Drug Administration (FDA) as an adjunctive therapy to
Lipid-lowering drugs.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2022 Sep 19;64(1659):145-152. Med Lett Drugs Ther. 2022. PMID: 36094548 No abstract available.
Lipid-lowering drugs.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Feb 11;61(1565):17-24. Med Lett Drugs Ther. 2019. PMID: 30845106 No abstract available.
Antilipemic Agents.
[No authors listed] [No authors listed] 2019 Jun 4. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2019 Jun 4. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643276 Free Books & Documents. Review.
Three bile acid sequestrants are available in the United States: cholestyramine (Questran: 1973), colestipol (Colestid: 1977) and colesevelam (Welchol: 2000). These agents are also used for therapy of pruritus for their activity in lowering the "pruritogens" that accumulat …
Three bile acid sequestrants are available in the United States: cholestyramine (Questran: 1973), colestipol (Colestid: 1977) and col …
Colestipol-induced hepatotoxicity.
Sirmans SM, Beck JK, Banh HL, Freeman DA. Sirmans SM, et al. Pharmacotherapy. 2001 Apr;21(4):513-6. doi: 10.1592/phco.21.5.513.34501. Pharmacotherapy. 2001. PMID: 11310528
A 65-year-old man with type IIa dyslipidemia who received flavored colestipol granules 2 scoops/day for 3 months developed asymptomatic hepatotoxicity. ...Four weeks after colestipol was discontinued, all liver function tests were normal. Rechallenge was not attempt …
A 65-year-old man with type IIa dyslipidemia who received flavored colestipol granules 2 scoops/day for 3 months developed asymptomat …
Treatment of hypercholesterolemia.
Kane JP, Malloy MJ. Kane JP, et al. Med Clin North Am. 1982 Mar;66(2):537-50. doi: 10.1016/s0025-7125(16)31434-1. Med Clin North Am. 1982. PMID: 7040850 Review.
Treatment of hypercholesterolemia.
Kane JP, Havel RJ. Kane JP, et al. Annu Rev Med. 1986;37:427-35. doi: 10.1146/annurev.me.37.020186.002235. Annu Rev Med. 1986. PMID: 3518611 Review. No abstract available.
554 results